Personal Accident and Health Insurance Market in Colombia

personal-accident-and-health-insurance-in-colombia

Personal Accident and Health Insurance in Colombia Key Trends and Opportunities to 2020 report provides a detailed outlook by product category for the Colombian life insurance segment, and a comparison of the Colombian insurance industry with its regional counterparts.

It provides key performance indicators such as written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, total assets, total investment income and retentions during the review period (20112015) and forecast period (20152020).

The report also analyzes distribution channels operating in the segment, gives a comprehensive overview of the Colombian economy and demographics, and provides detailed information on the competitive landscape in the country.
The report brings together research, modeling and analysis expertise, giving insurers access to information on segment dynamics and competitive advantages, and profiles of insurers operating in the country. The report also includes details of insurance regulations, and recent changes in the regulatory structure.

Personal Accident and Health Insurance in Colombia Key Trends and Opportunities to 2020 report provides in-depth market analysis, information and insights into the Colombian personal accident and health insurance segment, including:
An overview of the Colombian personal accident and health insurance segment
The Colombian personal accident and health insurance segments growth prospects by category
A comprehensive overview of the Colombian economy and demographics
A comparison of the Colombian personal accident and health insurance segment with its regional counterparts
The various distribution channels in the Colombian personal accident and health insurance segment

Details of the competitive landscape in the personal accident and health insurance segment in Colombia
Details of regulatory policy applicable to the Colombian insurance industry

Scope
This report provides a comprehensive analysis of the personal accident and health insurance segment in Colombia:
It provides historical values for the Colombian personal accident and health insurance segment for the reports 20112015 review period, and projected figures for the 20152020 forecast period.
It offers a detailed analysis of the key categories in the Colombian personal accident and health insurance segment, and market forecasts to 2020.
It provides a comparison of the Colombian personal accident and health insurance segment with its regional counterparts
It provides an overview of the various distribution channels for personal accident and health insurance products in Colombia.
It profiles the top personal accident and health insurance companies in Colombia, and outlines the key regulations affecting them.

Colombia has a highly competitive personal accident and health insurance segment, which includes both domestic and foreign insurance companies.
Private health insurance cover in the country increased among the poorest 20.0% of the population in 2015.
The penetration rate for the personal accident and health insurance segment was 0.27% in 2015.
The segments distribution network is dominated by direct marketing.

Ebolavirus Infections (Ebola Hemorrhagic Fever) – Pipeline Review, H2 2016

ebolavirus-infectionsSummary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Ebolavirus Infections (Ebola Hemorrhagic Fever) Pipeline Review, H2 2016, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline landscape.

Request for Sample Report @http://www.aarkstore.com/sample/296877

Ebola is a rare but deadly viral infection that causes bleeding inside and outside the body. Signs and symptoms include fever, severe headache, joint and muscle aches, sore throat, nausea and vomiting, diarrhea, chest pain and cough. Supportive therapy includes oxygen therapy, blood transfusions, intravenous fluids and pain relievers.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Ebolavirus Infections (Ebola Hemorrhagic Fever) Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease).
– The pipeline guide reviews pipeline therapeutics for Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) therapeutics and enlists all their major and minor projects.

Reasons to buy Market Report

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.

Best Selling Market Reports : 

Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2016

About Aarkstore:

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

Maximizing Direct-to-Consumer Opportunities in Insurance

insuranceSynopsis
Maximizing Direct-to-Consumer Opportunities in Insurance analyzes the state of the emerging online direct-to-consumer (D2C) channel in the global insurance industry. The insurance industry is going through a phase of digital transformation. This process has impacted the entire business function, from underwriting to claims management. The advance of technology has encouraged insurers to explore and establish D2C channels. According to the Global Insurance Industry Survey conducted by Timetric in May 2016, D2C emerged as a channel with growth prospects over the next 12 months.

Request for Sample Report @http://www.aarkstore.com/sample/289027
The report also discusses the trends and drivers relating to the adoption of D2C among insurers. The growing relevance of digital technology in insurance business models, and the need to strengthen their digital capability are motivating insurers to develop D2C channels. Insurers are being forced to explore new and more effective channels to enable customer interaction following a decline in sales through brokers and agents, particularly in mature economies. The ability to create a hybrid distribution model, combining agent-based capabilities with D2C platforms, stands to become a more effective distribution strategy.

Summary

Maximizing Direct-to-Consumer Opportunities in Insurance analyzes the emerging importance of the D2C channel in the insurance industry. It provides:

An overview of the D2C channel in the insurance industry by analyzing the rise in adoption of D2C among insurers.

Analysis of growth opportunities and challenges with respect to D2C channels.

Insights into the growing popularity of D2C, and the market trends and drivers.

Scope

Analysis of the opportunities provided by D2C in terms of new products and business segments.

An overview of the evolution of distribution channels in the insurance industry, and analysis of technological innovations in distribution.

Analysis of how insurers can enhance offerings by integrating digital technology into their business models.

Reasons To Buy Market Report
Gain an insight into how next-generation insurers are using the D2C platform to create new products and services.

Build an understanding of insurers digital investments.

Develop an insight into how insurers can capitalize on the opportunities provided by D2C in functions from product development to customer service.

Key Highlights
The advance of technology and the realization of opportunities in the digitization of insurance processes have encouraged providers to explore and establish D2C channels. Timetric found that the majority of startups aim to enable insurers to work with them on technology and consumer engagement, as opposed to disrupting and competing. Some are displacing agents by creating digital channels and addressing problems with the current model.

Insurers foresee a great deal of use of direct online channels as an alternative distribution channel. D2C can not only help insurers maximize sales, but also provide a range of services through an online platform. It lowers distribution costs and provides an opportunity for insurers to capitalize on direct interactions. Insurers which postpone their online presence will lose market share to competitors.

Best Selling Market Reports : 

Insight Report: The Future of Consumer Payments – Contactless Cards or NFC Mobile?

Insight Report: Is Mobile Point of Sale Changing the Retail World?

Insight Report: Competition in Mobile Payments – Apple, Samsung, Android, Alipay and PayPal

About Aarkstore:

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion By 2022

seasonal-influenza-vaccineSeasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022.

 

 

Request for Sample Report @http://www.aarkstore.com/sample/290187

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. The barriers limiting the growth of the influenza market include limited patient awareness regarding the threat of influenza and the importance of influenza vaccinations, high investment and strict regulations act as barriers for new entrants.

 

The United States seasonal influenza vaccine market is the most attractive of those covered in the report. The United States market for seasonal influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. United Kingdom will be the second–largest market for seasonal influenza vaccine which is expected to grow at a CAGR of XX% by 2022. Germany is expected to be third largest seasonal influenza vaccine market being followed by Japan by the end of the forecasted period.

 

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the seasonal influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the seasonal influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

 

Seven Major Markets(7MM) covered in the report are as follows:

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan

Major and Promising Vaccines covered in the report are as follows:

1. Fluzone High–Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN–100
11. M–001
12. VAX–2012Q
13. TAK – 850

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into seasonal influenza vaccine sales forecasts for the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape.

Best Selling Market Reports : 

Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016

Global Avian Influenza Vaccines Consumption 2016

United States Influenza Vaccine Industry 2016 Market Research Report

About Aarkstore:

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

 

The cloud systems management software market size is estimated to grow from USD 3.95 billion in 2016 to USD 15.29 billion by 2021

cloud-systems-management-softwareFactors such as growing need for integration of complex & heterogeneous cloud environments and increasing adoption of private & hybrid cloud are driving the cloud systems management software market

The cloud systems management software market size is estimated to grow from USD 3.95 billion in 2016 to USD 15.29 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 31.1%. The market is driven by factors such as increased demand for automation & control among enterprises and gaining visibility across workload to improve operation management. However, complexities in application portability and rising threats & data security concerns are some of the restraints that are hindering the growth of cloud systems management software adoption.

Request for Sample Report @http://www.aarkstore.com/sample/289012

Application performance management is expected to have the fastest growth rate during the forecast period

Enterprises use application performance management to manage and monitor the performance of complex and distributed software applications. The solution helps identify bottlenecks and quickly detects the root cause of application performance problems.

Professional services are expected to have largest market share, while managed services to grow at the highest CAGR

Professional services enable enterprises to choose the best possible solutions and services depending on the requirement of the businesses and their users. Vendors offering these services focus on improving the network performance, reducing the capital expenditure & operational expenditure, and ensuring end-to-end delivery and multivendor support.

Various key cloud systems management software providers profiled in the report are as follows:

1. VMware Inc. (California, U.S.)
2. IBM Corporation (New York, U.S.)
3. Microsoft Corporation (Washington, U.S.)
4. HP Enterprise Company (California, U.S.)
5. Cisco Systems, Inc. (California, U.S.)
6. BMC Software (Texas, U.S.)
7. Oracle Corporation (California, U.S.)

Research Coverage

The cloud systems management software market has been segmented based on solution, service, deployment, organisation size, vertical, and region. A detailed analysis of the key industry players has been done to provide key insights into their business overview, products & services, key strategies, new product launches, partnerships, agreements, & collaborations, business expansions, and competitive landscape associated with the cloud systems management software market.

The report will help the market leaders/new entrants in this market in the following ways:

• This report segments the cloud systems management software market comprehensively and provides the closest approximations of the revenue numbers for the overall market and the subsegments across different verticals and regions.

• This report helps stakeholders to understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

Best Selling Market Reports : 

http://www.aarkstore.com/information-technology/286089/public-safety-and-security-market-global-forecast-to-2021

http://www.aarkstore.com/information-technology/122676/digital-transformation-market-global-forecast-to-2021

http://www.aarkstore.com/information-technology/119231/facial-recognition-market-global-forecast-to-2021

About Aarkstore:

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

Worldwide 3D Printing Market in Aerospace and Consumer Electronics – Technologies, Materials, Regions – Drivers, Opportunities, Trends, and Forecasts- 2016-2022

3d-printersThe 3D printing market is a rapidly growing market. Since 2008, the 3D printing market has started penetrating in almost every industry vertical such as aerospace, manufacturing, healthcare, and consumer electronics. The less wastage compared to the traditional printing methods is one of the key reasons for the industries to adopt 3D printing methods. The interdependence of software, technology and material are contributing towards the success of the worldwide 3D printing market.

Request for Sample Report @http://www.aarkstore.com/sample/208056

According to Infoholic Research, the Worldwide 3D Printing in Aerospace and Consumer Electronics market will grow at an estimated CAGR of 28.2% during the forecast period 20162022. At present, the market is witnessing a twofold growth in the mature markets of North America and Europe. Although, for the past 23 years, the market has started experiencing growth in the Asia Pacific region specifically in the 3D printer market. Increase in the investment by the big players and growing Public Private Partnerships (PPPs) is helping in the 3D printing market growth in the aerospace industry. The demand for the sleek, light-weight and complex designed products are driving the 3D printing market in the consumer electronics industry.

Key players covered in the report are 3D Systems, Stratasys, Boeing, Aerojet Rocket Dyne, GE Aviation, Optomec, XYZ Printing, HP Development Company, Rolls-Royce, Safran Turbomeca and Airbus. The research report provides a comprehensive review of 3D printing technologies and 3D printing materials. The report also covers 3D printing market in aerospace and consumer electronics market in terms of trends, regions and vendor assessments on the basis of technology, R&D spendings, and product offerings.

The study covers and analyzes the Worldwide 3D Printing in Aerospace and Consumer Electronics market. Bringing out the complete key insights of the industry, the report aims to provide an opportunity for players to understand the latest trends, current market scenario, government initiative, and technologies related to the market. In addition, helps the venture capitalist in understanding the companies better and take informed decisions.

Best Selling Market Reports : 

The Software-controlled networking: worldwide forecast 2016–2020

United States 3D Printing Plastic Market Report 2016

Global 3D Printing Healthcare Market Professional Survey Report 2016

About Aarkstore:

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

Parkinsons Disease Therapeutics in Major Developed Markets to 2021

Description

Parkinson’s Disease (PD) is a progressive, chronic neurodegenerative condition, which is currently incurable. It is associated with old age, and characterized by the loss of neurons in the substantia nigra region of the brain. The global Parkinson’s Disease (PD) prevalence was estimated at 16.1 million in 2011, and after Alzheimer’s disease it is the second most common neurodegenerative disease worldwide.

Request for Sample Report @http://www.aarkstore.com/sample/194967

Parkinson’s Disease (PD) is a progressive disease and, although not fatal, it can develop severe symptoms and complications that significantly impact upon the patient’s quality of life. Symptoms for each stage can be categorized into early, moderate and advanced stages. Major motor symptoms of Parkinson’s Disease (PD) include tremors and difficulty walking. Parkinson’s Disease (PD) also gives rise to non-motor symptoms, such as dementia, depression, hallucinations and loss of taste and smell.

There are several different drug classes available to relieve Parkinson’s Disease (PD) symptoms. The aim is for treatments to increase dopamine levels, which is substantially diminished in brains affected by Parkinson’s Disease (PD). The most common therapies include levodopa, dopamine agonists and Monoamine Oxidase-B (MAO-B) inhibitors, with the choice of therapies dependent on patient symptoms and lifestyle. As the disease develops, the medication will need to be taken more strictly, due to the effect of drugs wearing off (known as off- time), which causes symptoms to return before the next dose.

Scope

A brief introduction to Parkinson’s Disease (PD), including pathogenesis, disease staging, diagnosis and treatment algorithms

Comprehensive analysis of the drugs available for the treatment of PD, covering their safety, efficacy, treatment patterns, and strengths/weaknesses, as well as a heat map comparing drugs in terms of safety and efficacy

Comprehensive analysis of the pipeline for Parkinson’s Disease (PD) therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period, on the basis of Phase distribution, molecule type and molecular target

Additional thorough analysis of pipeline drug clinical trials by Phase, molecule type, trial size, trial duration, and program failure rate for each molecule type and mechanism of action

Reasons To Buy Market Report

Understand the different levels of Parkinson’s Disease (PD) therapy from early-stage to advanced

Understand the vast scope of the pipeline, including which molecule types and mechanisms of action are prominent

Observe the trends in clinical trial duration and size among clinical Phases and molecule types, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or forthcoming developmental programs for Parkinson’s Disease (PD) therapeutics

Observe the trends in clinical trial duration and size among clinical Phases, between molecule types and mechanisms of action, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for Parkinson’s Disease (PD) therapeutics

Best Selling Market Reports : 

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) – Trends & Global Forecast to 2020

Internal Neurostimulation Market, by Type (Spinal Cord Stimulation, Deep brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation), by Application (Parkinson’s Disease, Chronic Pain), by Geography – Analysis & Forecasts To 2019

Global Huntingtons Disease Therapeutics Sales Market Report 2016

About Aarkstore:

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

%d bloggers like this: